CHRONIC ANOVULATION SYNDROME AND ASSOCIATED NEOPLASIA
- 1 January 1983
- journal article
- research article
- Vol. 61 (4) , 403-407
Abstract
Ovarian hormones have been implicated in a number of neoplastic conditions. Chronic anovulation syndrome, a spontaneous biologic experiment of unopposed secretion of estrogen by the ovaries, was identified in a cohort of 1270 patients, and the risk of these patients having neoplasia was studied. Of the 1270 patients studied, 30 had a subsequent malignancy develop; the expected number was 29.8. When the individual types of subsequent malignancy were analyzed, the endometrium was the only site at increased risk. The relative risk of developing carcinoma of the endometrium after the diagnosis of chronic anovulation syndrome is 3.1 (95% confidence interval 1.1-7.3). The long-term risk of developing adenocarcinoma of the endometrium might be considered when treating patients who have this syndrome.This publication has 9 references indexed in Scilit:
- A case-control study of menopausal estrogen therapy and breast cancerJAMA, 1980
- BREAST-CANCER INCIDENCE, PREVALENCE, MORTALITY, AND SURVIVORSHIP IN ROCHESTER, MINNESOTA, 1935 TO 19741980
- Effects of long-term estrogen replacement therapyAmerican Journal of Obstetrics and Gynecology, 1979
- Estrogen treatment of postmenopausal women. Benefits and risksJAMA, 1977
- Exogenous estrogen and endometrial carcinoma: Case-control and incidence studyAmerican Journal of Obstetrics and Gynecology, 1977
- ENDOMETRIAL CANCER ASSOCIATED WITH FEMINIZING OVARIAN TUMOR AND POLYCYSTIC OVARIAN DISEASE1977
- Menopausal Estrogens and Breast CancerNew England Journal of Medicine, 1976
- Granulosa cell tumor of the ovary and coincident carcinoma of the uterusAmerican Journal of Obstetrics and Gynecology, 1942
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896